Patents by Inventor Ning Jiao

Ning Jiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230112619
    Abstract: Provided is a method for preparing isoquinolinone compounds. The preparation method has the advantages of a reasonable route, convenient and easy operations, high preparation yield, high purity, and suitability for industrial production.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 13, 2023
    Inventors: Ning JIAO, Zhanqun ZHU, Guofeng SUN, Yanbin SONG, He XING, Xinchao WU
  • Publication number: 20220257764
    Abstract: The disclosure belongs to the technical field of medicine, and relates to use of a diketone compound in photodynamic therapy or diagnosis. Particularly, the disclosure relates to use of a compound of formula (I), pharmaceutically acceptable salt or ester, prodrug, stereoisomer, hydrate, solvate or crystal form of the compound, metabolite of each of them, or any combination or mixture thereof in preparation of a drug or a reagent. The drug or the reagent is used for photodynamic therapy or photodynamic diagnosis of a disease or is used for skin beauty by means of photodynamic therapy.
    Type: Application
    Filed: May 11, 2020
    Publication date: August 18, 2022
    Inventors: Ning JIAO, Jialiang WEI, Yameng LIU
  • Publication number: 20220119333
    Abstract: A phenoxy carboxylic acid compound, its pharmaceutically acceptable salt or ester, stereoisomer, prodrug, hydrate, solvate or crystal form, or metabolite form thereof, or any combination or mixture thereof; a pharmaceutical composition comprising the compound, its pharmaceutically acceptable salt or ester, stereoisomer, prodrug, hydrate, solvate or crystal form, or metabolite form thereof, or any combination or mixture thereof; and a medicinal use of the compound, its pharmaceutically acceptable salt or ester, stereoisomer, prodrug, hydrate, solvate or crystal form, or metabolite form thereof, or any combination or mixture thereof, for preventing and/or treatment of a metabolic disease (e.g., metabolic syndrome, non-alcoholic fatty liver disease, and/or diabetes mellitus).
    Type: Application
    Filed: August 23, 2019
    Publication date: April 21, 2022
    Applicant: QINGDAO WHOLESOMTECH CO., LTD.
    Inventors: Ning Jiao, Siwang Yu, Song Song, Yameng Liu, Simin Yang